Mifepristone and misoprostol australia - [BINGH2]

Abortion procedures - medication

Behind-the-news articles are published in response to issues that are of interest to the community at a point in time, for example, subjects that have been in the media.

Under the provisions of mifepristone registration, Marie Stopes International Australia is introducing the medicines in a controlled way for the safe use of the medicines, including a tailored educational package which they have developed and will be made available for medical practitioners who wish to prescribe mifepristone, mifepristone and misoprostol australia.

This will mean that only misoprostol practitioners recognised by Marie Stopes International Australia as having australia appropriate training will be able to prescribe the medicines.

and

Medication abortion

The decision to include Mifepristone on the Australian Register of Therapeutic Goods ARTG has followed the TGA process for all new registrations - assessment for efficacy, mifepristone and misoprostol australia, safety and quality for its intended indications. In keeping with publication of evaluation information on newly registered medicines, an Australian Product Assessment Report AusPARwhich summarises the issues considered by TGA and any of its Committees in the decision to register the two medicines, will be made available within 30 days of the medicines being included on the ARTG.

Mifepristone is a synthetic steroid with an anti-progestational action.

What it's like to take the abortion pill

Misoprostol is a synthetic analogue of prostaglandin E1 and induces contractions of the smooth muscle fibres in the myometrium and relaxation of the uterine cervix. The combination of misoprostol, used in a sequential regimen after mifepristone, mifepristone and misoprostol australia, has been used for over 20 years in mifepristone number of countries for medical termination of pregnancy.

Both surgical and medical termination methods australia risks and adverse effects associated with them, and decisions by a patient on the method of termination must be made in consultation with a medical misoprostol. Mifepristone Linepharma mg tablet is indicated in females of and age for: Medical termination of a developing intra-uterine pregnancy, in sequential combination with a prostaglandin analogue up to 49 days of gestation.

Preparation for the action of registered prostaglandin analogues that are indicated for australia termination of pregnancy for medical reasons beyond the first trimester. As with all misoprostol authorisation approvals, availability of mifepristone products will be managed by the sponsor - in this case, Marie Stopes And Australia, mifepristone and misoprostol australia.